275 related articles for article (PubMed ID: 21837355)
1. Angiogenesis in cancer. Basic mechanisms and therapeutic advances.
Prager GW; Poettler M
Hamostaseologie; 2012; 32(2):105-14. PubMed ID: 21837355
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic options to target angiogenesis in human malignancies.
Herbst RS
Expert Opin Emerg Drugs; 2006 Nov; 11(4):635-50. PubMed ID: 17064223
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor and vascular endothelial growth factor receptor inhibitors as anti-angiogenic agents in cancer therapy.
Veeravagu A; Hsu AR; Cai W; Hou LC; Tse VC; Chen X
Recent Pat Anticancer Drug Discov; 2007 Jan; 2(1):59-71. PubMed ID: 18221053
[TBL] [Abstract][Full Text] [Related]
4. Reassessing vascular endothelial growth factor (VEGF) in anti-angiogenic cancer therapy.
Elebiyo TC; Rotimi D; Evbuomwan IO; Maimako RF; Iyobhebhe M; Ojo OA; Oluba OM; Adeyemi OS
Cancer Treat Res Commun; 2022; 32():100620. PubMed ID: 35964475
[TBL] [Abstract][Full Text] [Related]
5. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
Zhao Y; Adjei AA
Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
[TBL] [Abstract][Full Text] [Related]
6. Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases.
Carmeliet P; Jain RK
Nat Rev Drug Discov; 2011 Jun; 10(6):417-27. PubMed ID: 21629292
[TBL] [Abstract][Full Text] [Related]
7. The role of angiogenesis in solid tumours: an overview.
Makrilia N; Lappa T; Xyla V; Nikolaidis I; Syrigos K
Eur J Intern Med; 2009 Nov; 20(7):663-71. PubMed ID: 19818284
[TBL] [Abstract][Full Text] [Related]
8. Role of tumour angiogenesis in haematological malignancies.
Medinger M; Passweg J
Swiss Med Wkly; 2014; 144():w14050. PubMed ID: 25375891
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis in spontaneous tumors and implications for comparative tumor biology.
Benazzi C; Al-Dissi A; Chau CH; Figg WD; Sarli G; de Oliveira JT; Gärtner F
ScientificWorldJournal; 2014; 2014():919570. PubMed ID: 24563633
[TBL] [Abstract][Full Text] [Related]
10. Molecular and cellular regulators of cancer angiogenesis.
Goh PP; Sze DM; Roufogalis BD
Curr Cancer Drug Targets; 2007 Dec; 7(8):743-58. PubMed ID: 18220534
[TBL] [Abstract][Full Text] [Related]
11. Anti-angiogenic therapy: concept to clinic.
Young RJ; Reed MW
Microcirculation; 2012 Feb; 19(2):115-25. PubMed ID: 22078005
[TBL] [Abstract][Full Text] [Related]
12. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications.
Ferrara N
Semin Oncol; 2002 Dec; 29(6 Suppl 16):10-4. PubMed ID: 12516033
[TBL] [Abstract][Full Text] [Related]
13. Novel pharmacologic approaches to the prevention and treatment of ulcerative colitis.
Deng X; Szabo S; Khomenko T; Tolstanova G; Paunovic B; French SW; Sandor Z
Curr Pharm Des; 2013; 19(1):17-28. PubMed ID: 22950505
[TBL] [Abstract][Full Text] [Related]
14. Molecular diagnosis of tumor angiogenesis and anti-angiogenic cancer therapy.
Sato Y
Int J Clin Oncol; 2003 Aug; 8(4):200-6. PubMed ID: 12955574
[TBL] [Abstract][Full Text] [Related]
15. Anti-Angiogenic Therapy: Current Challenges and Future Perspectives.
Lopes-Coelho F; Martins F; Pereira SA; Serpa J
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916438
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor: biology and therapeutic applications.
Ho QT; Kuo CJ
Int J Biochem Cell Biol; 2007; 39(7-8):1349-57. PubMed ID: 17537667
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor as a therapeutic target in cancer.
Bergsland EK
Am J Health Syst Pharm; 2004 Nov; 61(21 Suppl 5):S4-11. PubMed ID: 15552621
[TBL] [Abstract][Full Text] [Related]
18. Tumor angiogenesis and vascular normalization: alternative therapeutic targets.
Viallard C; Larrivée B
Angiogenesis; 2017 Nov; 20(4):409-426. PubMed ID: 28660302
[TBL] [Abstract][Full Text] [Related]
19. The vascular endothelial growth factor (VEGF) signaling pathway: a therapeutic target in patients with hematologic malignancies.
Giles FJ
Oncologist; 2001; 6 Suppl 5():32-9. PubMed ID: 11700390
[TBL] [Abstract][Full Text] [Related]
20. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
